Evan Thackaberry - 06 Jan 2022 Form 3 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
SVP, Head of Early Development
Signature
/s/ Jennifer Ziolkowski, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
06 Jan 2022
Net transactions value
$0
Form type
3
Filing time
06 Jan 2022, 19:37:40 UTC
Next filing
03 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VIGL Stock Option Grant (Right to Buy) 06 Jan 2022 Common Stock 89,942 $1.89 Direct F1
holding VIGL Stock Option Grant (Right to Buy) 06 Jan 2022 Common Stock 37,476 $3.78 Direct F2
holding VIGL Stock Option Grant (Right to Buy) 06 Jan 2022 Common Stock 20,601 $6.02 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option vested and became exercisable on September 21, 2021, with the remainder vesting in 36 equal monthly installments thereafter.
F2 25% of the shares subject to this option shall vest and become exercisable on June 1, 2022, with the remainder vesting in 36 equal monthly installments thereafter.
F3 The shares subject to this option vest and become exercisable in 48 equal monthly installments, with the first installment vested September 13, 2021.

Remarks:

Exhibit 24 - Power of Attorney